Dara Biosciences, Inc. Receivables Turnover Ratio (DARA), from the third quarter 2015 to the third quarter 2014 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Dara Biosciences, Inc.  (DARA)
 

Dara Biosciences Accounts Receivables Turnover Ratio from the third quarter 2015 to the third quarter 2014

Quarterly Results, Trends, Rankings, Statistics


Dara Biosciences, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2015 to a ratio of 3.06, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2015. Average receivable collection period, for the Dara Biosciences in Sep 30 2015 quarter, has decreased to 119 days, compared to 130 days, in the Jun 30 2015 quarter.

If we take a look into Healthcare sector 276 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2015 from to 3083.

What is Receivable Turnover Ratio?
What is Dara Biosciences, Inc. Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DARA Receivables Turnover Ratio (Sep 30 2015)
III. Quarter		 (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter
Y / Y Receivable Change 148.62 % 200.31 % 305.92 % 1033.86 % 220.87 %
Y / Y Revenue Change 188.5 % 513.5 % 257.72 % 330.42 % 432.13 %
Receivable Turnover Ratio (TTM) 3.06 2.81 2.23 1.91 3.45
DARA's Total Ranking # 3083 # # # #
Accounts Receivable average collection period days 119 130 164 191 106
Seq. Receivable Change 50.25 % 33.04 % -70.84 % 326.51 % 81.49 %
Seq. Revenue Change 19.21 % 51.92 % 9.1 % 46.02 % 153.5 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 88
Healthcare Sector # 277
Overall Market # 3083

Receivable Turnover Ratio Statistics
High Average Low
2.71 2.29 1.88
(Dec 31 2013)   (Sep 30 2013)





DARA Company Profile • Back to DARA Efficiency Comparisons • Compare DARA Receivables Turnover Ratio to its Competitors

Financial Statements
Dara Biosciences's Accounts Receivable $ 1 Millions Visit DARA's Balance sheet
Dara Biosciences's Sales TTM $ 3 Millions Visit DARA's Income Statement
Sources of DARA's Revenues Visit DARA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DARA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DARA's Growth Rates DARA's Roa DARA's Inventory Turnover Ratio DARA's Dividend Comparisons
DARA's Profitability Ratios DARA's Roi DARA's Asset Turnover Ratio DARA's Dividend Growth
DARA's Valuation Ratios DARA's Roe DARA's Financial Strength Ratios DARA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2015, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2015 Receivable at quarter ending Sep 30 2015
Biodelivery Sciences International Inc   8.16 $ 18.569  Millions$ 2.276  Millions
Antares Pharma Inc   8.16 $ 42.256  Millions$ 5.182  Millions
Heska Corporation  8.13 $ 99.161  Millions$ 12.194  Millions
Travere Therapeutics Inc   8.13 $ 83.530  Millions$ 10.272  Millions
Enzo Biochem Inc  8.11 $ 97.952  Millions$ 12.085  Millions
Quest Diagnostics Inc  8.07 $ 7,527.000  Millions$ 933.000  Millions
Neurometrix Inc   7.98 $ 5.972  Millions$ 0.748  Millions
Oxford Immunotec Global Plc  7.98 $ 58.115  Millions$ 7.287  Millions
Amgen Inc   7.97 $ 21,457.000  Millions$ 2,693.500  Millions
Cambrex Corp  7.96 $ 406.454  Millions$ 51.053  Millions
Tenet Healthcare Corp  7.96 $ 19,166.000  Millions$ 2,408.750  Millions
Biogen Inc   7.94 $ 10,565.139  Millions$ 1,330.260  Millions
Novavax inc   7.93 $ 37.122  Millions$ 4.681  Millions
Alpha Pro Tech Ltd   7.85 $ 47.153  Millions$ 6.005  Millions
Utah Medical Products Inc  7.84 $ 40.818  Millions$ 5.206  Millions
Sintx Technologies Inc   7.83 $ 19.509  Millions$ 2.492  Millions
Aveo Pharmaceuticals Inc   7.83 $ 15.541  Millions$ 1.986  Millions
Option Care Health Inc   7.73 $ 1,024.596  Millions$ 132.534  Millions
Merit Medical Systems Inc  7.70 $ 536.525  Millions$ 69.654  Millions
Patterson Companies Inc   7.66 $ 4,962.843  Millions$ 648.300  Millions
Lhc Group Inc   7.65 $ 790.744  Millions$ 103.351  Millions
Bard C R Inc  7.64 $ 3,412.400  Millions$ 446.825  Millions
Ufp Technologies Inc   7.63 $ 140.184  Millions$ 18.367  Millions
Community Health Systems Inc   7.63 $ 27,066.217  Millions$ 3,548.000  Millions
Icu Medical Inc  7.60 $ 331.177  Millions$ 43.579  Millions
Ensign Group Inc  7.60 $ 1,245.540  Millions$ 163.924  Millions
Champions Oncology Inc   7.58 $ 10.862  Millions$ 1.434  Millions
Inotiv Inc   7.57 $ 22.698  Millions$ 3.000  Millions
Positron Corporation  7.54 $ 1.237  Millions$ 0.164  Millions
Invacare Holdings Corporation  7.54 $ 1,177.272  Millions$ 156.232  Millions

Date modified: 2026-09-02T17:50:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.